Loading clinical trials...
Loading clinical trials...
An Exploratory Study of Conversion Therapy With Sintilimab Plus CAPOX in Patients With Unresectable Locally Advanced or Limited Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction
Conditions
Interventions
sintilimab
Locations
1
China
West China Hospital, Sichuan University
Chengdu, Sichuan, China
Start Date
March 1, 2020
Primary Completion Date
May 1, 2021
Completion Date
October 1, 2021
Last Updated
February 11, 2020
NCT04704661
NCT06901531
NCT07462923
NCT05677490
NCT04511039
NCT07001748
Lead Sponsor
Sichuan University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions